References
- Loh E, St John Sutton M, Wun CC et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N. Engl. J. Med.336, 251–257 (1997).
- Teo KK, Yusuf S, Pfeffer M et al. Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet360, 1037–1043 (2002).
- Massie BM, Krol WF, Ammon SE et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J. Card. Fail.10, 101–112 (2004).
- Massie BM. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH). Presented at the American College of Cardiology Annual Scientific Session, New Orleans, USA. March 2004.
- Cleland JGF, Findlay I, Jafri S et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies in patients with heart failure. Am. Heart J.148, 157–164 (2004).
- Masoudi FA, Wolfe P, Havranek et al. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J. Am. Coll. Cardiol.46, 955–962 (2005).